Cargando…
Cell Surface Fibroblast Activation Protein-2 (Fap2) of Fusobacterium nucleatum as a Vaccine Candidate for Therapeutic Intervention of Human Colorectal Cancer: An Immunoinformatics Approach
Colorectal cancer (CRC) is one of the most common cancers and is the second-highest in cancer-related deaths worldwide. The changes in gut homeostasis and microbial dysbiosis lead to the initiation of the tumorigenesis process. Several pathogenic gram-negative bacteria including Fusobacterium nuclea...
Autores principales: | Padma, Somrita, Patra, Ritwik, Sen Gupta, Parth Sarthi, Panda, Saroj Kumar, Rana, Malay Kumar, Mukherjee, Suprabhat |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10056511/ https://www.ncbi.nlm.nih.gov/pubmed/36992108 http://dx.doi.org/10.3390/vaccines11030525 |
Ejemplares similares
-
Designing AbhiSCoVac - A single potential vaccine for all ‘corona culprits’: Immunoinformatics and immune simulation approaches
por: Choudhury, Abhigyan, et al.
Publicado: (2022) -
Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy
por: Ganesan, Kumar, et al.
Publicado: (2019) -
Immunogenicity of a Fap2 peptide mimotope of Fusobacterium nucleatum and its potential use in the diagnosis of colorectal cancer
por: Guevarra, Leonardo A., et al.
Publicado: (2018) -
Fusobacterium nucleatum and cancer
por: Alon‐Maimon, Tamar, et al.
Publicado: (2022) -
Repurposing of FDA-approved drugs as potential inhibitors of the SARS-CoV-2 main protease: Molecular insights into improved therapeutic discovery
por: Ray, Abhik Kumar, et al.
Publicado: (2022)